Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GPR3 Ligands Discovered through Combined Virtual and Conformational Biosensor-Based Screening.

Journal of the American Chemical Society·2026
Same author

Machine Learning-Boosted Docking Enables the Efficient Structure-Based Virtual Screening of Giga-Scale Enumerated Chemical Libraries.

Journal of chemical information and modeling·2023
Same author

Frizzled BRET sensors based on bioorthogonal labeling of unnatural amino acids reveal WNT-induced dynamics of the cysteine-rich domain.

Science advances·2021
Same author

Rare genetic variability in human drug target genes modulates drug response and can guide precision medicine.

Science advances·2021
Same author

Residue 6.43 defines receptor function in class F GPCRs.

Nature communications·2021
Same author

Machine Learning Boosted Docking (HASTEN): An Open-source Tool To Accelerate Structure-based Virtual Screening Campaigns.

Molecular informatics·2021

Related Experiment Video

Updated: Jun 20, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

5.4K

SpaceHASTEN: A Structure-Based Virtual Screening Tool for Nonenumerated Virtual Chemical Libraries.

Tuomo Kalliokoski1, Ainoleena Turku1, Heikki Käsnänen1

  • 1Orion Pharma, Orionintie 1A, 02101 Espoo, Finland.

Journal of Chemical Information and Modeling
|December 23, 2024
PubMed
Summary

Exploring vast chemical spaces for drug discovery is challenging. A new tool, SpaceHASTEN, enables efficient structure-based virtual screening of non-enumerated chemical spaces, identifying novel drug candidates.

More Related Videos

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.0K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

Related Experiment Videos

Last Updated: Jun 20, 2026

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin
06:29

Workflow and Tools for Crystallographic Fragment Screening at the Helmholtz-Zentrum Berlin

Published on: March 3, 2021

5.4K
Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

5.0K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

4.7K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • cheminformatics

Background:

  • Fully enumerating chemical libraries for drug discovery is computationally infeasible due to vast chemical space.
  • Non-enumerated virtual chemical spaces offer a practical alternative, representing compounds as building blocks connected by rules.
  • Existing tools for searching these spaces primarily use ligand-based methods, lacking protein structure-based screening capabilities.

Purpose of the Study:

  • To develop a novel hybrid ligand/structure-based virtual screening tool, SpaceHASTEN.
  • To enable efficient structure-based virtual screening of non-enumerated chemical spaces using protein structure as input.
  • To address the gap in software for screening non-enumerated chemical spaces with protein structure queries.

Main Methods:

  • Development of SpaceHASTEN, integrating SpaceLight, FTrees, LigPrep, and Glide.
  • Utilizing a hybrid approach combining ligand-based and structure-based virtual screening methods.
  • Validation using three public targets from the DUD-E dataset.

Main Results:

  • SpaceHASTEN successfully performed structure-based virtual screening on non-enumerated chemical spaces.
  • The tool identified a substantial number of diverse and novel high-scoring compounds (virtual hits).
  • Screening millions of compounds allowed retrieval of hits from billions of molecules in the chemical space.

Conclusions:

  • SpaceHASTEN provides an efficient solution for structure-based virtual screening of large, non-enumerated chemical spaces.
  • The developed tool facilitates the discovery of novel drug candidates by leveraging protein structure information.
  • The freely available software offers a valuable resource for computational drug discovery efforts.